Vertex has reached a key moment because the U.S. Food and Drug Administration (FDA) is reviewing its candidate, suzetrigine, ...

Looking at longer-term growth for Legend. We recently announced a new research facility being built in Philadelphia, which is ...

BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...

Analyst Emily Bodnar of H.C. Wainwright maintained a Buy rating on IO Biotech (IOBT – Research Report), retaining the price target of ...

WINNIPEG, Manitoba, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the "Company”, "Kane Biotech”) announces today that it has entered into a binding term sheet (the ...

Ramaswamy is now part of Donald Trump’s future Department of Government Efficiency. Learn how he made his fortune and where ...

Industry experts from across 100 countries will descend on Riyadh this December for launch event of most comprehensive pharma ...

A Baltimore jury found two drug distributors liable for contributing to the city's ongoing opioid crisis. The decision came ...

Tharimmune, Inc. (NASDAQ:THAR) (”Tharimmune” or the “Company”), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in inflammation and immunology, announced today ...

Two pharmaceutical companies have been found liable in Baltimore's opioid epidemic. McKesson and AmerisourceBergen have been ...

BioNTech has agreed to acquire biotechnology company Biotheus for $800 million up front and up to $150 million in milestone payments. The German developer of RNA vaccines and immunotherapies said ...

While everyone's attention is focused on Mineral Resources and WiseTech, there are other companies on the ASX that are ...